UK Markets close in 7 hrs 58 mins

Mauna Kea Technologies SA (MKEAF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.40000.0000 (0.00%)
At close: 08:44AM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.4000
Open1.4000
Bid0.0000 x 0
Ask0.0000 x 0
Day's range1.4000 - 1.4000
52-week range1.3300 - 2.2000
Volume1,000
Avg. volume0
Market cap58.675M
Beta (5Y monthly)1.86
PE ratio (TTM)N/A
EPS (TTM)-0.4750
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Mauna Kea Technologies Reports Fourth Quarter and Full Year 2021 Sales

    PARIS & BOSTON, January 20, 2022--Regulatory News: Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced fourth quarter and full year 2021 sales.

  • Business Wire

    Mauna Kea Technologies Provides Business Update

    PARIS & BOSTON, January 13, 2022--Regulatory News: Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces a board-approved plan designed to reduce operating expenses and maximize capital resources in order to support the Company's strategic focus on the use of Cellvizio as an aid for real-time characterization of lung cancer and for molecular imaging g

  • Business Wire

    Mauna Kea Technologies Announces Strategic Realignment

    PARIS & BOSTON, December 13, 2021--Regulatory News: Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, announced a realignment of the organization designed to improve operating efficiency, increase the company’s cash runway, and focus resources on Cellvizio’s highest potential clinical applications, including interventional pulmonology and molecular imaging.